OTC Market in CIS Countries 2013, Russia, Ukraine and Kazakhstan

Publisher Name :
Date:31-Oct-2013
No. of pages: 176

How popular are OTC products in the CIS countries in 2013?

Report compares, analyses market data and forecasts for Russia, Ukraine and Kazakhstan.

Over the counter drugs and a growing selection of dietary supplements are gaining popularity among health conscious people everywhere. Consequently, the markets for these preparations are expanding across the CIS region, particularly in the countries of Russia, Ukraine and Kazakhstan. Opportunities exist for businesses involved in the manufacture, distribution and wholesale and retail sales of these products in the years ahead.

To alert industry professionals of important upcoming events in the market, PMR has prepared the newest edition of its report – OTC market in CIS countries 2013, Russia, Ukraine and Kazakhstan. Comparative analysis and development forecasts for 2013-2015. It contains comprehensive descriptions of the markets in each country, plus consumer preference data, detailed forecasts and profiles of the major manufacturers.

This report gathers and presents a wealth of expert analysis and historical data that comes as a result of years of close observation of the market by the PMR team of experienced analysts. It presents market data from each of the three covered countries in a manner that facilitates comparison among the markets and makes important decision-making and strategic planning simpler and more accurate. Readers will discover which country offers the greatest room for growth and the most valuable OTC market for drugs and dietary supplements.

This publication features coverage of trends in each country, as well as the top selling over the counter remedies. It details the value and structure of OTC markets and their main segments, while examining the share of the overall pharmaceutical markets in each country occupied by the OTC industry. The profiles of leading OTC manufacturers in the region are presented, along with consumer preferences and purchasing habits.

The report examines key market trends and predicts their likely impact on sales over the forecast period, along with the strategic choices that companies are willing to make in order to increase market share. It considers spending on advertising and other strategies being used by companies to expand the marketplace.

OTC manufacturing, sales and distribution professionals will turn to this valuable document when they need to evaluate the competition, choose a new location for an expansion or create a new sales strategy for a particular type of OTC product. Financial services, consulting and research service providers use it to locate and serve new clients with interests in this market, and government agencies consult its pages when assessing the effects of old regulations on market value or developing new legislation for the pharmaceutical sectors in each of the three CIS countries covered by OTC market in CIS countries 2013, Russia, Ukraine and Kazakhstan. Comparative analysis and development forecasts for 2013-2015.

OTC Market in CIS Countries 2013, Russia, Ukraine and Kazakhstan

Table Of Contents

I. Methodology p. 11

II. Executive summary p. 15

III. OTC market in CIS countries p. 19

IV. Advertising p. 95

V. Key manufacturers p. 119

VI. Factors influencing OTC market in CIS countries p. 159

VII. List of graphs p. 165

VIII. List of tables p. 173

IX. About PMR p. 175

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • 2014 Deep Research Report on Global and China Intravenous Catheter Industry
    Published: 22-Jul-2014        Price: US $2200 Onwards        Pages: 184
    This is a professional and depth research report on China Intravenous Catheter industry. The report firstly introduced Intravenous Catheter basic information included Intravenous Catheter definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Intravenous Catheter industry policy and plan, Intravenous Catheter product specification, man......
  • 2014 Deep Research Report on Global and China Particulate Respirators Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 150
    This is a professional and depth research report on Global and China Particulate Respirators industry. The report firstly introduced Particulate Respirators basic information included Particulate Respirators definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Particulate Respirators industry policy and plan, Particulate Respirators product specif......
  • 2014 Deep Research Report on Global and China Sialic Acid Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 136
    This is a professional and depth research report on Global and China Sialic Acid industry. The report firstly introduced Sialic Acid basic information included Sialic Acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Sialic Acid industry policy and plan, Sialic Acid product specification, manufacturing process, cost structure etc. then sta......
  • OpportunityAnalyzer: Dengue Vaccines – Opportunity Analysis and Forecasts to 2020
    Published: 17-Jul-2014        Price: US $5995 Onwards        Pages: 189
    Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges......
  • Spain Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 100
    BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to contain expenditure on prescription medicines by targeting patients, companies and the overall healthcare sector present challenges to drugmakers operating in the country. Despite calls made by companies for the implementation of a system that adequately rewards innovation and supports investment in future medicines, the government is likely to remain committed to fiscal consolidation and will conti......
  • Ghana Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: Continuing depreciation in the Ghanaian currency has led us to revise our headline forecasts in USD for the pharmaceutical sector downwards. In the long-term however we remain positive for the sector with the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical company interest in the country and capacity building initiatives for bringing global quality control standards to Ghanaian pharmaceutical industry will spur domestic demand and regional expor......
  • Greece Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: The Greek pharmaceutical and healthcare sector will continue contract over the medium-tolong term. Although Greece's financial outlook has stabilised and debts are being paid down, the government will continue to target the pharmaceutical and healthcare industry to reduce public spending. We highlight, however, that the generic drug sector and private healthcare industry will present some growth opportunities in the country. Headline Expenditure Projections ? Pharmaceuticals: EUR......
  • Lithuania Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 97
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8%, rising to a value of LTL2.11bn (USD732mn) in 2018. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost of increasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania with little leeway to increase its healthcare spending dramatically over the next five years. Th......
  • Moldova Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 96
    BMI View: BMI has upgraded its forecast for Moldova's pharmaceutical and healthcare market for 2014 due to improved economic conditions. Moldova is likely to sign the Association Agreement with the EU in June 2014, which would strengthen the business environment and improve the regulatory structure and access to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcare sector with the World Bank, which is likely to be positive for the sector. Any retaliatory......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs